Cited by 590Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration MechanismsSingle-cell and spatial transcriptomics

Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state

Open access
Smajić, Semra, Prada-Medina, Cesar A., Landoulsi, Zied, Ghelfi, Jenny, Delcambre, Sylvie, Dietrich, Carola, Jarazo, Javier, Henck, Jana +11 more·2022·Brain

Published version of a preprint

Abstract

Idiopathic Parkinson’s disease is characterized by a progressive loss of dopaminergic neurons, but the exact disease aetiology remains largely unknown. To date, Parkinson’s disease research has mainly focused on nigral dopaminergic neurons, although recent studies suggest disease-related changes also in non-neuronal cells and in midbrain regions beyond the substantia nigra. While there is some evidence for glial involvement in Parkinson’s disease, the molecular mechanisms remain poorly understood. The aim of this study was to characterize the contribution of all cell types of the midbrain to Parkinson’s disease pathology by single-nuclei RNA sequencing and to assess the cell type-specific risk for Parkinson’s disease using the latest genome-wide association study. We profiled >41 000 single-nuclei transcriptomes of post-mortem midbrain from six idiopathic Parkinson’s disease patients and five age-/sex-matched controls. To validate our findings in a spatial context, we utilized immunolabelling of the same tissues. Moreover, we analysed Parkinson’s disease-associated risk enrichment in genes with cell type-specific expression patterns. We discovered a neuronal cell cluster characterized by CADPS2 overexpression and low TH levels, which was exclusively present in idiopathic Parkinson’s disease midbrains. Validation analyses in laser-microdissected neurons suggest that this cluster represents dysfunctional dopaminergic neurons. With regard to glial cells, we observed an increase in nigral microglia in Parkinson’s disease patients. Moreover, nigral idiopathic Parkinson’s disease microglia were more amoeboid, indicating an activated state. We also discovered a reduction in idiopathic Parkinson’s disease oligodendrocyte numbers with the remaining cells being characterized by a stress-induced upregulation of S100B. Parkinson’s disease risk variants were associated with glia- and neuron-specific gene expression patterns in idiopathic Parkinson’s disease cases. Furthermore, astrocytes and microglia presented idiopathic Parkinson’s disease-specific cell proliferation and dysregulation of genes related to unfolded protein response and cytokine signalling. While reactive patient astrocytes showed CD44 overexpression, idiopathic Parkinson’s disease microglia revealed a pro-inflammatory trajectory characterized by elevated levels of IL1B, GPNMB and HSP90AA1. Taken together, we generated the first single-nuclei RNA sequencing dataset from the idiopathic Parkinson’s disease midbrain, which highlights a disease-specific neuronal cell cluster as well as ‘pan-glial’ activation as a central mechanism in the pathology of the movement disorder. This finding warrants further research into inflammatory signalling and immunomodulatory treatments in Parkinson’s disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awab446

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Smajić, S., Prada-Medina, C. A., Landoulsi, Z., Ghelfi, J., Delcambre, S., Dietrich, C., Jarazo, J., Henck, J., Balachandran, S., Pachchek, S., Morris, C. M., Antony, P., Timmermann, B., Sauer, S., Pereira, S. L., Schwamborn, J. C., May, P., Grünewald, A., & Spielmann, M.
Affiliations
  • University of Luxembourg (LU)
  • Max Planck Institute for Molecular Genetics, D-14195 Berlin, Germany
  • Max Planck Institute for Molecular Genetics (DE)
  • Christian-Albrechts-Universität zu Kiel (DE)
  • Newcastle University (GB)
  • Max Delbrück Center (DE)
Corresponding author
  • Grünewald, Anne
  • Spielmann, Malte
Venue
Brain
Published
2021-12-17
Volume
145
Issue
3
Pages
964-978
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W4200349851
Cited by
590
References
80
Citations by year
2026: 148 · 2025: 147 · 2024: 150 · 2023: 96 · 2022: 43 · 2021: 4 · 2012: 1
FWCI
38.40
Type
journal article
Language
en
Open access
Locations
  • Brain (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
  • Open Repository and Bibliography (University of Luxembourg) (submittedVersion, other-oa)
  • Newcastle University ePrints (Newcastle Univesity) (cc-by)
Funders
  • Luxembourg National Research Fund (PRIDE17/12244779/PARK-QC)
  • Le Foyer Assurances Luxembourg
  • National Centre of Excellence in Research on Parkinson’s disease
  • ‘MiRisk-Parkinson’s disease’ (C17/BM/11676395)
  • ‘ProtectMove’ (INTER/DFG/19/14429377)
  • Deutsche Forschungsgemeinschaft (SP1532/3-1, SP1532/4-1, SP1532/5-1)
  • Deutsches Zentrum für Luft- und Raumfahrt
  • Newcastle Brain Tissue Resource from UK MRC (MR/L016451/1)
  • National Institutes for Health Research Biomedical Research Centre Newcastle
  • Parkinson’s UK (258197, SC037554)
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
Keywords
Parkinson's disease, midbrain, single-nucleus RNA sequencing, glial activation, microglia, oligodendrocytes, astrocytes, dopaminergic neurons, Th, S100B, unfolded protein response, cytokine signaling, IL1B, GPNMB, HSP90AA1, CD44
MeSH terms
Humans, Membrane Glycoproteins, Mesencephalon, Parkinson Disease, Substantia Nigra, Microglia, Genome-Wide Association Study, Dopaminergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review